ELVN vs LYFT · $2.11B cap vs P/E 108, rev $3.49B
Enliven Therapeutics Inc. (ELVN) versus LYFT Inc (LYFT) — a side-by-side from cached financials, not a winner call.
Enliven Therapeutics Inc. (ELVN) is a biotechnology company listed on US.
LYFT Inc (LYFT) is a software - application company listed on US. It is led by David Risher.
ELVN does not have a complete income-statement cache yet.
Latest reported LYFT revenue for 2026-06-30 was $3.49B. Net income was $64.5M. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
ELVN currently screens at market cap $2.11B. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
Not investment advice. Open the ELVN and LYFT stock pages for the full models.
Not investment advice.